FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898151911> ?p ?o ?g. }

• W2898151911 endingPage "e194" @default.
• W2898151911 startingPage "e187" @default.
• W2898151911 abstract "Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.We conducted a multicenter retrospective analysis in the Triveneto region of Italy.One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined." @default.
• W2898151911 created "2018-11-02" @default.
• W2898151911 creator A5006321826 @default.
• W2898151911 creator A5010573143 @default.
• W2898151911 creator A5011844809 @default.
• W2898151911 creator A5022699386 @default.
• W2898151911 creator A5025797878 @default.
• W2898151911 creator A5026461288 @default.
• W2898151911 creator A5030122361 @default.
• W2898151911 creator A5034356923 @default.
• W2898151911 creator A5034433849 @default.
• W2898151911 creator A5040080252 @default.
• W2898151911 creator A5046583306 @default.
• W2898151911 creator A5047868780 @default.
• W2898151911 creator A5065833805 @default.
• W2898151911 creator A5065945024 @default.
• W2898151911 creator A5067706322 @default.
• W2898151911 creator A5070427131 @default.
• W2898151911 creator A5077284495 @default.
• W2898151911 creator A5082704939 @default.
• W2898151911 creator A5087431312 @default.
• W2898151911 date "2019-02-01" @default.
• W2898151911 modified "2023-10-14" @default.
• W2898151911 title "Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region" @default.
• W2898151911 cites W2000159285 @default.
• W2898151911 cites W2034235423 @default.
• W2898151911 cites W2095914632 @default.
• W2898151911 cites W2101265600 @default.
• W2898151911 cites W2110534364 @default.
• W2898151911 cites W2120292596 @default.
• W2898151911 cites W2123526148 @default.
• W2898151911 cites W2132315278 @default.
• W2898151911 cites W2132611552 @default.
• W2898151911 cites W2137467802 @default.
• W2898151911 cites W2141454098 @default.
• W2898151911 cites W2142466432 @default.
• W2898151911 cites W2148643283 @default.
• W2898151911 cites W2150865892 @default.
• W2898151911 cites W2154361786 @default.
• W2898151911 cites W2166918329 @default.
• W2898151911 cites W2210989209 @default.
• W2898151911 cites W2289770060 @default.
• W2898151911 cites W2620746860 @default.
• W2898151911 cites W2620798309 @default.
• W2898151911 cites W2762767318 @default.
• W2898151911 cites W2774510604 @default.
• W2898151911 cites W2781525129 @default.
• W2898151911 cites W2800198416 @default.
• W2898151911 cites W2905153461 @default.
• W2898151911 doi "https://doi.org/10.1016/j.clgc.2018.10.013" @default.
• W2898151911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30448106" @default.
• W2898151911 hasPublicationYear "2019" @default.
• W2898151911 type Work @default.
• W2898151911 sameAs 2898151911 @default.
• W2898151911 citedByCount "13" @default.
• W2898151911 countsByYear W28981519112020 @default.
• W2898151911 countsByYear W28981519112021 @default.
• W2898151911 countsByYear W28981519112022 @default.
• W2898151911 crossrefType "journal-article" @default.
• W2898151911 hasAuthorship W2898151911A5006321826 @default.
• W2898151911 hasAuthorship W2898151911A5010573143 @default.
• W2898151911 hasAuthorship W2898151911A5011844809 @default.
• W2898151911 hasAuthorship W2898151911A5022699386 @default.
• W2898151911 hasAuthorship W2898151911A5025797878 @default.
• W2898151911 hasAuthorship W2898151911A5026461288 @default.
• W2898151911 hasAuthorship W2898151911A5030122361 @default.
• W2898151911 hasAuthorship W2898151911A5034356923 @default.
• W2898151911 hasAuthorship W2898151911A5034433849 @default.
• W2898151911 hasAuthorship W2898151911A5040080252 @default.
• W2898151911 hasAuthorship W2898151911A5046583306 @default.
• W2898151911 hasAuthorship W2898151911A5047868780 @default.
• W2898151911 hasAuthorship W2898151911A5065833805 @default.
• W2898151911 hasAuthorship W2898151911A5065945024 @default.
• W2898151911 hasAuthorship W2898151911A5067706322 @default.
• W2898151911 hasAuthorship W2898151911A5070427131 @default.
• W2898151911 hasAuthorship W2898151911A5077284495 @default.
• W2898151911 hasAuthorship W2898151911A5082704939 @default.
• W2898151911 hasAuthorship W2898151911A5087431312 @default.
• W2898151911 hasConcept C121608353 @default.
• W2898151911 hasConcept C126322002 @default.
• W2898151911 hasConcept C126894567 @default.
• W2898151911 hasConcept C141071460 @default.
• W2898151911 hasConcept C143998085 @default.
• W2898151911 hasConcept C167135981 @default.
• W2898151911 hasConcept C2777783956 @default.
• W2898151911 hasConcept C2779466945 @default.
• W2898151911 hasConcept C2780192828 @default.
• W2898151911 hasConcept C2780737065 @default.
• W2898151911 hasConcept C2780739268 @default.
• W2898151911 hasConcept C2781190966 @default.
• W2898151911 hasConcept C3019894029 @default.
• W2898151911 hasConcept C71924100 @default.
• W2898151911 hasConceptScore W2898151911C121608353 @default.
• W2898151911 hasConceptScore W2898151911C126322002 @default.
• W2898151911 hasConceptScore W2898151911C126894567 @default.
• W2898151911 hasConceptScore W2898151911C141071460 @default.
• W2898151911 hasConceptScore W2898151911C143998085 @default.
• W2898151911 hasConceptScore W2898151911C167135981 @default.

• next